Nov 23, 2017Inflection Biosciences & RCSI enter research collaboration to target Therapy Resistant BC treatment.Dublin, Ireland, November 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, and...
Nov 2, 2017Inflection Biosciences to Present at Investor Conferences in November 2017Dublin, Ireland, November 2, 2017 Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
Jun 23, 2017Inflection Biosciences Announces Pre-clinical Data to be Presented at 2nd EACR-AACR-SIC Special ConfDublin, Ireland, June 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...
May 15, 2017Inflection Biosciences Announces Pre-clinical Data on IBL-202 to be Presented at IWCLL 2017Dublin, Ireland, May 15th, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today...